Pyrexia of undetermined origin in the era of HAART
Open Access
- 1 December 2000
- journal article
- case report
- Published by BMJ in Sexually Transmitted Infections
- Vol. 76 (6) , 484-488
- https://doi.org/10.1136/sti.76.6.484
Abstract
In the past the patient had had hepatitis A in 1990 and was first found to be HIV-1 antibody positive in April 1999, at which time the CD4+ T lymphocyte count was 220 cells ×106/l and HIV viral load was 421 400 copies/ml (Chiron quantiplex b DNA assay v 3.0). An STD screen was negative and he was hepatitis B immune. At the time of diagnosis of HIV infection he had declined HAART as he was asymptomatic but had started co-trimoxazole as primary prophylaxis against Pneumocystis carinii pneumonia. He was subsequently monitored in the outpatient clinic on a regular basis. In late 1999 his CD4+ T lymphocyte count began to fall. By early February 2000 it was 70 cells ×106/l and the HIV viral load was 308 900 copies/ml. The patient began zidovudine 250 mg twice daily, lamivudine 150 mg twice daily, and efavirenz 600 mg at night, 10 days before admission to hospital.Keywords
This publication has 7 references indexed in Scilit:
- The treatment of tuberculosis in HIV-infected personsAIDS, 1999
- HIV combination therapyAIDS, 1998
- Diagnostic utility of fine needle aspiration (FNA) cytology in HIV‐infected patients with lymphadenopathyCytopathology, 1998
- HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy.1998
- Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 diseaseThe Lancet, 1998
- Pyrexia of undetermined origin in patients with human immunodeficiency virus infection and AIDSInternational Journal of STD & AIDS, 1996
- Cryptococcal pneumonia in AIDS: is cryptococcal meningitis preceded by clinically recognizable pneumonia?1995